Cytovance Biologics

Virocell Biologics is a contract development and manufacturing organization (CDMO) that manufactures viral vectors.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Manufacturer of clinical products intended to focus on injectable pharmaceutical and biotech compounds. The company provides support for its pharmaceutical and biotech clients in the early stages of development from clinical phases and regulatory approval to worldwide product launch their commercial manufacturing handles the entire production process, enabling clients to avail of the required services.